Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis

B Rocca, KAA Fox, RA Ajjan, F Andreotti… - European heart …, 2018 - academic.oup.com
The success of trials that have shown net clinical benefits of antithrombotic drugs as well as
the increasing prevalence of cardiovascular diseases in an ageing population have led to …

[HTML][HTML] Clinical guidelines for drug-related peptic ulcer

MK Joo, CH Park, JS Kim, JM Park, JY Ahn, BE Lee… - Gut and liver, 2020 - ncbi.nlm.nih.gov
Korean guidelines for nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcer
were previously developed in 2009 with the collaboration of the Korean College of …

Effects of dabigatran according to age in atrial fibrillation

MN Lauw, JW Eikelboom, M Coppens, L Wallentin… - Heart, 2017 - heart.bmj.com
Objective The prevalence of atrial fibrillation (AF) and the risk of stroke and bleeding vary
according to age. To estimate effects of dabigatran, compared with warfarin, on stroke …

Risk of gastrointestinal bleeding during anticoagulant treatment

A Lanas-Gimeno, A Lanas - Expert opinion on drug safety, 2017 - Taylor & Francis
Introduction: Gastrointestinal bleeding (GIB) is a major problem in patients on oral
anticoagulation therapy. This issue has become even more pressing since the introduction …

Digoxin is associated with a decreased incidence of angiodysplasia-related gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices

S Vukelic, PP Vlismas, SR Patel, X Xue… - Circulation: Heart …, 2018 - Am Heart Assoc
Background: Gastrointestinal bleeding (GIB) is one of the principal adverse events affecting
patients with continuous-flow left ventricular assist devices (CF-LVADs). Despite the early …

[HTML][HTML] Challenges of anticoagulant therapy in atrial fibrillation—focus on gastrointestinal bleeding

A Scridon, AI Balan - International Journal of Molecular Sciences, 2023 - mdpi.com
The rising prevalence and the complexity of atrial fibrillation (AF) pose major clinical
challenges. Stroke prevention is accompanied by non-negligible risks, making anticoagulant …

Aktualisierte S2k-Leitlinie Helicobacterpylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und …

W Fischbach, J Bornschein… - Zeitschrift für …, 2023 - thieme-connect.com
Die Prävalenz der Helicobacter pylori-Infektion (H. pylori-Infektion) liegt in Deutschland bei
etwa 30% und stellt die häufigste Ursache der gastroduodenalen Ulkuskrankheit …

[HTML][HTML] Drug-associated gastropathy: diagnostic Criteria

DS Bordin, MA Livzan, OV Gaus, SI Mozgovoi, A Lanas - Diagnostics, 2023 - mdpi.com
Drugs are widely used to treat different diseases in modern medicine, but they are often
associated with adverse events. Those located in the gastrointestinal tract are common and …

Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models

X Sun, Y Su, X Liu, Y Zhang, Y He, W Han… - Bone Marrow …, 2021 - nature.com
Gastrointestinal bleeding (GIB) accounts for a significant proportion of life-threatening
bleeding cases occurring after allogeneic haematopoietic stem cell transplantation (allo …

Management of oral anticoagulation therapy after gastrointestinal bleeding: whether to, when to, and how to restart an anticoagulation therapy

K Kido, MJ Scalese - Annals of Pharmacotherapy, 2017 - journals.sagepub.com
Objective: To evaluate current clinical evidence for management of oral anticoagulation
therapy after gastrointestinal bleeding (GIB) with an emphasis on whether to, when to, and …